These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 17706529

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. F-18 Fluorodeoxyglucose-Positron Emission Tomography Imaging for Primary Breast Cancer and Loco-Regional Staging.
    Avril N, Adler LP.
    PET Clin; 2006 Jan; 1(1):1-13. PubMed ID: 27156954
    [Abstract] [Full Text] [Related]

  • 3. Positron emission tomography for the diagnosis of breast cancer.
    Rosé C, Dose J, Avril N.
    Nucl Med Commun; 2002 Jul; 23(7):613-8. PubMed ID: 12089482
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical application of 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in breast cancer.
    Bernsdorf M, Graff J.
    Clin Physiol Funct Imaging; 2014 Nov; 34(6):426-33. PubMed ID: 24267489
    [Abstract] [Full Text] [Related]

  • 8. [The value of F-18 fluorodeoxyglucose in positron emission tomography diagnosis of breast carcinoma].
    Langsteger W, Jörg L, Tausch C, Heinisch M, Wieser B, Rechberger E, Panholzer PJ, Sega W, Aufschnaiter M.
    Wien Med Wochenschr; 2002 Nov; 152(11-12):255-8. PubMed ID: 12138651
    [Abstract] [Full Text] [Related]

  • 9. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
    Gallowitsch HJ, Kresnik E, Gasser J, Kumnig G, Igerc I, Mikosch P, Lind P.
    Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
    [Abstract] [Full Text] [Related]

  • 10. [Possible uses of positron emission tomography in breast carcinoma].
    Römer W, Avril N, Schwaiger M.
    Acta Med Austriaca; 1997 May; 24(2):60-2. PubMed ID: 9273807
    [Abstract] [Full Text] [Related]

  • 11. Fluorodeoxyglucose-PET in the management of breast cancer.
    Kumar R, Alavi A.
    Radiol Clin North Am; 2004 Nov; 42(6):1113-22, ix. PubMed ID: 15488561
    [Abstract] [Full Text] [Related]

  • 12. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
    Yun M, Lim JS, Noh SH, Hyung WJ, Cheong JH, Bong JK, Cho A, Lee JD.
    J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
    [Abstract] [Full Text] [Related]

  • 13. Detection of breast cancer in an FDG-PET cancer screening program: results of a nationwide Japanese survey.
    Minamimoto R, Senda M, Jinnouchi S, Terauchi T, Yoshida T, Inoue T.
    Clin Breast Cancer; 2015 Apr; 15(2):e139-46. PubMed ID: 25454690
    [Abstract] [Full Text] [Related]

  • 14. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD, Schauwecker D, Davidson D, Logan T, Coleman JJ, Hutchins G, Love C, Wenck S, Daggy J.
    Cancer; 2005 Aug 01; 104(3):570-9. PubMed ID: 15977211
    [Abstract] [Full Text] [Related]

  • 15. Positron emission tomography in diagnosis and management of invasive breast cancer: current status and future perspectives.
    Wu D, Gambhir SS.
    Clin Breast Cancer; 2003 Apr 01; 4 Suppl 1():S55-63. PubMed ID: 12756080
    [Abstract] [Full Text] [Related]

  • 16. Role of positron emission tomography/computed tomography in breast cancer.
    Bourgeois AC, Warren LA, Chang TT, Embry S, Hudson K, Bradley YC.
    Radiol Clin North Am; 2013 Sep 01; 51(5):781-98. PubMed ID: 24010906
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC).
    Bellon JR, Livingston RB, Eubank WB, Gralow JR, Ellis GK, Dunnwald LK, Mankoff DA.
    Am J Clin Oncol; 2004 Aug 01; 27(4):407-10. PubMed ID: 15289736
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.